2026 MCM | Applying New Endocrine and Targeted Agents to the Treatment of Hormone Receptor Positive, HER2 Negative Breast Cancer

2026 MCM | Applying New Endocrine and Targeted Agents to the Treatment of Hormone Receptor Positive, HER2 Negative Breast Cancer

Overview

NA

Target Audience

Physicians
Nurses
Pharmacists
Physician Associates

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Bora Lim, MD

Date of Release

January 24th, 2026